Table 5.
Cross-immunization experiments
| Immunizing peptide | % of peptide-positive hybridomas | % of peptide-specific hybridomas responding to GAD65 protein |
|---|---|---|
| 456–470 (PD epitope) | 448/405 = 89% | 0/41 = 0% |
| 331–345 (PD epitope) | 458/504 = 91% | 0/48 = 0% |
| 206–220 (g7 epitope) | 144/168 = 85% | 40/48 = 83% |
NOD mice were immunized with two PD epitopes (p456–470 or p331–345), 50 μg emulsified in complete Freund’s adjuvant (CFA), to generate PD epitope-specific. I-Ag7 restricted T cell hybridomas. In another group, NOD mice were immunized with a g7 epitope (p206–p220), 50 μg in CFA, to generate p206–220-specific, I-Ag7-restricted T cell hybridomas. The percentage of peptide-positive hybridomas represents the ratio of the number of peptide-responding T cell hybridomas to the total number of screened hybridomas. The percentage of peptide-specific hybridomas responding to GAD65 protein represents the ratio of the number of peptide-responding T cell hybridomas responding to GAD65 to the total number of peptide-responding T cell hybridomas that were screened.